Original language | English |
---|---|
Publisher | National Institute for Health and Care Excellence |
Commissioning body | National Institute for Health and Care Excellence |
Publication status | Published - 3 Aug 2022 |
Asciminib for chronic myeloid leukaemia after two or more tyrosine kinase inhibitors
Peter James Murphy, Alexis Llewellyn, Nick Meader, Robert Hodgson, Mark Crawford Simmonds*
*Corresponding author for this work
Research output: Book/Report › Commissioned report